Paediatric network
Each centre brings together clinicians and translational scientists to run early-phase clinical trials for children and young people affected by cancer.
Paediatric centres
Our 12 paediatric centres function as a single virtual centre to improve patient recruitment and expand geographical access to novel anticancer agents.
The foundation of each centre is a partnership between local NHS Trusts and the university where the centre is based. They are also closely integrated with wider clinical research systems across all four countries of the UK.
Five of the centres are designated as first-in-child centres by the Innovative Therapies for Children with Cancer European Consortium (ITCC).
Our paediatric centre locations
Capabilities and services
Experimental medicine expertise
Our network brings together the UK’s leading oncology opinion leaders in precision medicine, novel trial design and translational research.
State-of-the-art research infrastructure
Our centres combine specialist clinical and laboratory facilities, patient identification technology and digital tools to deliver cutting-edge research.
Highly skilled, multi-disciplinary teams
Delivery teams at each centre include experienced research nurses, pharmacists, statisticians, data managers and trial operations managers.
Support and expertise
Our programme office
Our programme office supports the set-up and delivery of clinical research studies and encourages collaboration across the network. We are a single-entry point to our network, developing partnerships with sponsors and connecting them with the right sites to run their clinical trial.
Directory of expertise
Access our directory of expertise for support and advice on your experimental cancer medicine-related research questions, projects and opportunities. We can connect you with the right scientific, translational and clinical expertise within our network.
Our capabilities
We have a proven track record of delivering complex, early-phase oncology trials involving novel therapies, supported by comprehensive genomic profiling and extensive translational research expertise. Our portfolio spans first-in-class and first-in-child studies, alongside precision medicine and complex innovative trial designs.
You might also be interested in
Adult network
Our 17 adult centres across the UK are increasing access to novel treatments for adults with cancer.
Industry and partners
We are a centralised platform for commercial partners to launch trials quickly with access to expert teams, sites and processes.
Cross-Centre Placement Scheme
This scheme can support training, shadowing and initial collaboration meetings across the network.